TIMBAL v2: update of a database holding small molecules modulating protein–protein interactions
Open accessThe DOI matches its Crossref record; 14 of the 18 references it cites were found in a registry or an index.
Abstract
TIMBAL is a database holding molecules of molecular weight <1200 Daltons that modulate protein-protein interactions. Since its first release, the database has been extended to cover 50 known protein-protein interactions drug targets, including protein complexes that can be stabilized by small molecules with therapeutic effect. The resource contains 14 890 data points for 6896 distinct small molecules. UniProt codes and Protein Data Bank entries are also included. Database URL: http://www-cryst.bioc.cam.ac.uk/timbal
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To date, many PPI modulators have been developed and some of these have even successfully entered the clinic [30–33].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“To date, numerous modulators have been developed to target PPIs, and many of them have successfully entered the clinic.312–316”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [314]
In the citing paper
“Thirdly, targeting PPIs with covalent inhibitors is not possible if an appropriate nucleophilic residue is not available in the protein-binding interface, especially free cysteine, lysine, or methionine residues [32, 33].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Ongoing and future developments at the Universal Protein Resource
The UniProt Consortium (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1020 · Cited by 729
Morelli, X., Bourgeas, R., & Roche, P. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.024 · Cited by 223
Thiel, P., Kaiser, M., & Ottmann, C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107616 · Cited by 207
Protein–protein interactions as targets for small molecule drug discovery
Fry, D. C. (2006) · Peptide Science · doi:10.1002/bip.20608 · Cited by 206
Shi, A., Murai, M. J., He, S., Lund, G., Hartley, T., Purohit, T., Reddy, G., Chruszcz, M., Grembecka, J., & Cierpicki, T. (2012) · Blood · doi:10.1182/blood-2012-05-429274 · Cited by 204
ASD: a comprehensive database of allosteric proteins and modulators
Huang, Z., Zhu, L., Cao, Y., Wu, G., Liu, X., Chen, Y., Wang, Q., Shi, T., Zhao, Y., Wang, Y., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1022 · Cited by 181
Higueruelo, A. P., Schreyer, A. M., Bickerton, G. R., Pitt, W. R., Groom, C. R., & Blundell, T. L. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00889.x · Cited by 166
Self-citation2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions
Basse, M. J., Betzi, S., Bourgeas, R., Bouzidi, S., Chetrit, B., Hamon, V., Morelli, X., & Roche, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1002 · Cited by 148
Cited by
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Lagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017) · Scientific Reports · doi:10.1038/srep46277 · Cited by 266
Jubb, H. C., Pandurangan, A. P., Turner, M. A., Ochoa‐Montaño, B., Blundell, T. L., & Ascher, D. B. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.10.002 · Cited by 169
Self-citationFlexibility and small pockets at protein–protein interfaces: New insights into druggability
Jubb, H. C., Blundell, T. L., & Ascher, D. B. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.01.009 · Cited by 169
Self-citationVilloutreix, B. O., Kuenemann, M. A., Poyet, J., Bruzzoni‐Giovanelli, H., Labbé, C. M., Lagorce, D., Spérandio, O., & Miteva, M. A. (2014) · Molecular Informatics · doi:10.1002/minf.201400040 · Cited by 125
Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
Macalino, S. J. Y., Basith, S., Clavio, N. A. B., Chang, H., Kang, S., & Choi, S. (2018) · Molecules · doi:10.3390/molecules23081963 · Cited by 125
Targeting protein–protein interactions, a wide open field for drug design
Bakail, M., & Ochsenbein, F. (2016) · Comptes Rendus. Chimie · doi:10.1016/j.crci.2015.12.004 · Cited by 117
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
In silico structure-based approaches to discover protein-protein interaction-targeting drugs
Shin, W., Christoffer, C. W., & Kihara, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.006 · Cited by 91
Challenges in natural product-based drug discovery assisted with in silico -based methods
Simoben, C. V., Babiaka, S. B., Moumbock, A. F. A., Namba-Nzanguim, C. T., Eni, D. B., Medina‐Franco, J. L., Günther, S., Ntie‐Kang, F., & Sippl, W. (2023) · RSC Advances · doi:10.1039/d3ra06831e · Cited by 86
Basse, M.-J., Betzi, S., Morelli, X., & Roche, P. (2016) · Database · doi:10.1093/database/baw007 · Cited by 83
Computer-Aided Drug Discovery for Undruggable Targets
Sun, Q., Wang, H., Xie, J., Wang, L., Mu, J., Li, J., Ren, Y., & Lai, L. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00969 · Cited by 82
Sudha, G., Nussinov, R., & Srinivasan, N. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.07.004 · Cited by 73
Johnson, D. K., & Karanicolas, J. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00572 · Cited by 67
Kuenemann, M. A., Spérandio, O., Labbé, C. M., Lagorce, D., Miteva, M. A., & Villoutreix, B. O. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.02.006 · Cited by 64
Boyenle, I. D., Divine, U. C., Adeyemi, R. O., Ayinde, K. S., Olaoba, O. T., Apu, C., Du, L., Lü, Q., Yin, X., & Adelusi, T. I. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105577 · Cited by 62
iPPI-DB: an online database of modulators of protein–protein interactions
Labbé, C. M., Kuenemann, M. A., Zarzycka, B. A., Vriend, G., Nicolaes, G. A. F., Lagorce, D., Miteva, M. A., Villoutreix, B. O., & Spérandio, O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv982 · Cited by 62
Rational design of protein–protein interaction inhibitors
Rognan, D. (2014) · MedChemComm · doi:10.1039/c4md00328d · Cited by 61
Structure-based inhibition of protein–protein interactions
Watkins, A. M., & Arora, P. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.047 · Cited by 64
Stabilization of protein–protein interaction complexes through small molecules
Zarzycka, B. A., Kuenemann, M. A., Miteva, M. A., Nicolaes, G. A. F., Vriend, G., & Spérandio, O. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.011 · Cited by 58
Gou, Y., Liu, D., Chen, M., Wei, Y., Huang, X., Han, C., Feng, Z., Zhang, C., Lu, T., Peng, D., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae346 · Cited by 51
Survey of Similarity-Based Prediction of Drug-Protein Interactions
Wang, C., & Kurgan, L. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190808154841 · Cited by 52
The iPPI-DB initiative: a community-centered database of protein–protein interaction modulators
Torchet, R., Druart, K., Ruano, L. C., Moine-Franel, A., Borges, H., Doppelt‐Azeroual, O., Brancotte, B., Mareuil, F., Nilges, M., Ménager, H., et al. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa1091 · Cited by 52
Hamon, V., Bourgeas, R., Ducrot, P., Théret, I., Xuereb, L., Basse, M. J., Brunel, J. M., Combes, S., Morelli, X., & Roche, P. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0860 · Cited by 50
Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions
Bosc, N., Müller, C., Hoffer, L., Lagorce, D., Bourg, S., Derviaux, C., Gourdel‐Martin, M., Rain, J., Miller, T. W., Villoutreix, B. O., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00179 · Cited by 47
Protein–Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery
Milhas, S., Raux, B., Betzi, S., Derviaux, C., Roche, P., Restouin, A., Basse, M.-J., Rebuffet, E., Lugari, A., Badol, M., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00286 · Cited by 44
Which three-dimensional characteristics make efficient inhibitors of protein–protein interactions?
Kuenemann, M. A., Bourbon, L. M. L., Labbé, C. M., Villoutreix, B. O., & Sperandio, O. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500487q · Cited by 42
Zhang, X., Betzi, S., Morelli, X., & Roche, P. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.57 · Cited by 44
Ghanakota, P., van Vlijmen, H., Sherman, W., & Beuming, T. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00487 · Cited by 40
Camps-Fajol, C., Cavero, D., Minguillón, J., & Surrallés, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107544 · Cited by 36
pdCSM-PPI: Using Graph-Based Signatures to Identify Protein–Protein Interaction Inhibitors
Rodrigues, C. H. M., Pires, D. E. V., & Ascher, D. B. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01135 · Cited by 37
Current Trends in Macrocyclic Drug Discovery and beyond -Ro5
Alihodžić, S., Bukvić, M., Elenkov, I., Hutinec, A., Koštrun, S., Pešić, D., Saxty, G., Tomašković, L., & Žiher, D. (2018) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2018.01.002 · Cited by 36
Mizukoshi, Y., Takeuchi, K., Tokunaga, Y., Matsuo, H., Imai, M., Fujisaki, M., Kamoshida, H., Takizawa, T., Hanzawa, H., & Shimada, I. (2020) · Science Advances · doi:10.1126/sciadv.abd0480 · Cited by 32
Kuenemann, M. A., Labbé, C. M., Cerdan, A. H., & Spérandio, O. (2016) · Scientific Reports · doi:10.1038/srep23815 · Cited by 32
Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment
Shehroz, M., Zaheer, T., & Hussain, T. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05278 · Cited by 30
Small Molecule Targeting of Protein–Protein Interactions through Allosteric Modulation of Dynamics
Cossins, B. P., & Lawson, A. D. G. (2015) · Molecules · doi:10.3390/molecules200916435 · Cited by 32
Zhang, Z., Zhao, L., Wang, J., & Wang, C. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3384238 · Cited by 31
Trisciuzzi, D., Nicolotti, O., Miteva, M. A., & Villoutreix, B. O. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.013 · Cited by 28
Ikeda, K., Maezawa, Y., Yonezawa, T., Shimizu, Y., Tashiro, T., Kanai, S., Sugaya, N., Masuda, Y., Inoue, N., Niimi, T., et al. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2022.1090643 · Cited by 25
Gowthaman, R., Miller, S. A., Rogers, S. A., Khowsathit, J., Lan, L., Bai, N., Johnson, D. K., Liu, C., Xu, L., Anbanandam, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00150 · Cited by 25
Decoding Protein-protein Interactions: An Overview
Slater, O., Miller, B., & Kontoyianni, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200226105312 · Cited by 23
Shimizu, Y., Yonezawa, T., Sakamoto, J., Furuya, T., Osawa, M., & Ikeda, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-86616-1 · Cited by 23
Using a stacked ensemble learning framework to predict modulators of protein–protein interactions
Gao, M., Zhao, L., Zhang, Z., Wang, J., & Wang, C. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107032 · Cited by 22
Trisciuzzi, D., Villoutreix, B. O., Siragusa, L., Baroni, M., Cruciani, G., & Nicolotti, O. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2218641 · Cited by 22
Composition of Overlapping Protein-Protein and Protein-Ligand Interfaces
Mohamed, R., Degac, J., & Helms, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140965 · Cited by 17
Mapping of Protein-Protein Interactions: Web-Based Resources for Revealing Interactomes
Gemović, B., Šumonja, N., Davidović, R., Perović, V., & Veljković, N. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180214113704 · Cited by 18
Machine Learning Models to Predict Protein–Protein Interaction Inhibitors
Díaz‐Eufracio, B. I., & Medina‐Franco, J. L. (2022) · Molecules · doi:10.3390/molecules27227986 · Cited by 17
Natural products used as a chemical library for protein–protein interaction targeted drug discovery
Jin, X., Lee, K., Kim, N. H., Kim, H. S., Yook, J. I., Choi, J., & No, K. T. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.015 · Cited by 15
The Discovery of Cryptic Pockets Increases the Druggability of “Undruggable” Proteins
Mou, M., Yang, W., Huang, G., Yang, X., Zhang, X. L., Kandegama, W., Ashby, C. R., Hao, G., & Gao, Y. (2025) · Medicinal Research Reviews · doi:10.1002/med.70001 · Cited by 15
SInCRe—structural interactome computational resource forMycobacterium tuberculosis
Metri, R., Hariharaputran, S., Ramakrishnan, G., Anand, P., Raghavender, U. S., Ochoa‐Montaño, B., Higueruelo, A. P., Sowdhamini, R., Chandra, N. R., Blundell, T. L., et al. (2015) · Database · doi:10.1093/database/bav060 · Cited by 14
Self-citationExploring the chemical space of protein–protein interaction inhibitors through machine learning
Choi, J., Yun, J. S., Song, H., Kim, N. H., Kim, H. S., & Yook, J. I. (2021) · Scientific Reports · doi:10.1038/s41598-021-92825-5 · Cited by 14
Protein-Protein Interactions: Structures and Druggability
Ascher, D. B., Jubb, H. C., Pires, D. E. V., Ochi, T., Higueruelo, A. P., & Blundell, T. L. (2015) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-94-017-9719-1_12 · Cited by 14
Self-citationDiPPI: A Curated Data Set for Drug-like Molecules in Protein–Protein Interfaces
Cankara, F., Senyuz, S., Sayin, A. Z., Gürsoy, A., & Keskin, Ö. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01905 · Cited by 11
Ramakrishnan, G., Chandra, N. R., & Srinivasan, N. (2014) · IUBMB Life · doi:10.1002/iub.1331 · Cited by 10
Mayol, G. F., Defelipe, L. A., Arcon, J. P., Turjanski, A. G., & Marti, M. A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00264 · Cited by 10
Zhang, Z., Zhao, L., Gao, M., Chen, Y., Wang, J., & Wang, C. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108287 · Cited by 7
Hafiz, A., Bakri, R. A., Alsaad, M., Fetni, O. M., Alsubaihi, L. I., & Shamshad, H. (2022) · Pharmaceuticals · doi:10.3390/ph15060691 · Cited by 6
Khan, A., Munir, M., Aiman, S., Wadood, A., & Khan, A. (2017) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.12.014 · Cited by 6
Privileged Substructures to Modulate Protein–Protein Interactions
Bosc, N., Kuenemann, M. A., Becot, J., Vavruša, M., Cerdan, A. H., & Spérandio, O. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00435 · Cited by 6
Multimodal Contrastive Learning for Protein–Protein Interaction Inhibitor Prediction
Zhang, Z., Wang, Z., Zhao, L., Wang, J., & Wang, C. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822227 · Cited by 5
Alam, A., Fernández-Cabezudo, M. J., Hamoudi, R., & al-Ramadi, B. K. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-026-00698-z · Cited by 5
Les chimiothèques ciblant les interactions protéine-protéine
Spérandio, O., Villoutreix, B. O., Morelli, X., & Roche, P. (2015) · médecine/sciences · doi:10.1051/medsci/20153103017 · Cited by 5
Si, Y., Xu, D. D., Bum‐Erdene, K., Ghozayel, M. K., Yang, B., Clemons, P. A., & Meroueh, S. O. (2018) · ChemMedChem · doi:10.1002/cmdc.201800537 · Cited by 5
Lee, J., Lee, D., & Lee, K. H. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3396-y · Cited by 5
Fragment-Based Drug Discovery for Developing Inhibitors of Protein-Protein Interactions
Xiong, B., Wang, Q., & Shen, J. (2018) · Springer eBooks · doi:10.1007/978-981-13-0773-7_6 · Cited by 5
Targeting Protein–Protein Interactions Perspective
Chung, C., & Hann, M. M. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch20 · Cited by 6
Predicting the Likelihood of Molecules to Act as Modulators of Protein–Protein Interactions
Wolk, O., & Goldblum, A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00920 · Cited by 4
Strategies for in Silico Drug Discovery to Modulate Macromolecular Interactions Altered by Mutations
Poudel, P., Miteva, M. A., & Alexov, E. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26339 · Cited by 3
Structural Chemogenomics Databases to Navigate Protein–Ligand Interaction Space
Kanev, G. K., Kooistra, A. J., de Esch, I. J. P., & de Graaf, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12298-x · Cited by 3
The nucleoside adenosine inhibits intracellular microvascular α2C-adrenoceptor surface trafficking
Shahwar, D. E., Saeed, M., Hazrat, H., Javaid, S., Mohsin, S., Ul‐Haq, Z., & Chotani, M. A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133637 · Cited by 2
Drug Design Methods to Regulate Protein–Protein Interactions
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_6 · Cited by 4
PDID: Database of Experimental and Putative Drug Targets in Human Proteome
Wang, C., Bryliński, M., & Kurgan, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00028-6 · Cited by 2
Zhang, X. (2014) · theses.fr (ABES) · doi:10.70675/5d88c6d0zc4e5z4377za838z39c3e22fcd34 · Cited by 2
Dong, Z., Han, P., Li, X., Wang, S., Liu, L., & Song, T. (2026) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2026.3657905 · Cited by 1
A Structural View on Druggability
Egner, U., & Hillig, R. C. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch2 · Cited by 1
High Throughput Screening Methods for PPI Inhibitor Discovery
Doyle, S. P., Mo, X., Qian, K., Cicka, D., Niu, Q., & Fu, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00049 · Cited by 1
Predicting small-molecule inhibition of protein complexesPreprint
Yaseen, A., Roy, S., Akhter, N., Ben‐Hur, A., & Minhas, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.23.609286 · Cited by 1
Villoutreix, B. O., Kuenemann, M. A., Lagorce, D., Spérandio, O., & Miteva, M. A. (2015) · CRC Press eBooks · doi:10.1201/b18799-21
Contemporary Considerations for Discovering a Successful Medicine
Hann, M. M., Bayliss, M. K., & Leach, A. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12310-8
Johnson, D. K. (2016) · KU ScholarWorks (The University of Kansas)
Brunel, J. M., Combes, S., Morelli, X., Roche, P., Hamon, V., Théret, I., & Xuereb, L. (2013)
Modulation of protein : protein interactions in inflammatory diseases
Zarzycka, B. A. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20150702bz
Han, L., & Wang, R. (2018) · Springer eBooks · doi:10.1007/978-981-13-0773-7_4
Structural Investigation of Binding Events in Proteins
Clark, J. J. (2018) · Deep Blue (University of Michigan)
Tangadu, S., Shankar, S., Varanasi, B. V., & Athri, P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/667329
Sonawane, K. D., & Priya, V. G. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821748-1.00010-5
Jahnke, W. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738775439.793580691
Lee, J., Lee, D., & Lee, K. H. (2020) · Figshare · doi:10.6084/m9.figshare.13147253
HIV nucleaire import en chromatine lezing als nieuwe doelwitten voor geneesmiddelenontwikkeling
Blokken, J. (2018) · Lirias
Protein-protein interaction inhibitors in cancer
Hardcastle, I. R., Goujon-Ricci, J., & Thompson, W. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00067-4
Développement d'outils pour l'étude des interactions protéine-protéine
Milhas, S. (2016) · theses.fr (ABES) · doi:10.70675/7dcf6f45z231cz483fzb8f5z5cd27c8b0499
Ciblage des chaperons d'histone par une stratégie peptidomimétique
Bakail, M. (2016) · theses.fr (ABES) · doi:10.70675/4ea70173z53a2z43bfza23cz2f5f690aa5d7
Cartographie des interfaces protéine-protéine et recherche de cavités droguables
Silva, F. D. (2016) · theses.fr (ABES) · doi:10.70675/5ed407d7z4b6cz4e08z94f5ze7c2cc4fd624
Moine-Franel, A. (2023) · theses.fr (ABES) · doi:10.70675/4450e2b8z4b01z4798zbea5z3615171c406a
Protein–protein interaction inhibitors in the human proteome: lessons from 117 targeted interactions
Hyde, E., & Beekman, A. M. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00552g
Застосування розрахункових методів молекулярного моделювання для пошуку стабілізаторів когезину
Бояринов, М. Д. (2025) · Electronic Kharkiv National University Institutional Repository (Kharkiv National University)
Jana, T., Karmakar, J., Banerjee, R., & Saha, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10659504/v1
Metadata
- Authors
- Higueruelo, A. P., Jubb, H., & Blundell, T. L.
- Affiliations
- Department of Biochemistry, University of Cambridge, Cambridge CB1 2GA, UK
- University of Cambridge (GB)
- Venue
- Database
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-01
- Volume
- 2013
- Pages
- bat039-bat039
- ISSN
- 1758-0463 (ISSN-L)
- PMC
- PMC3681332
- OpenAlex
- W2121666644
- Cited by
- 93
- References
- 18
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 12 · 2019: 3 · 2018: 9 · 2017: 7 · 2016: 9 · 2015: 14 · 2014: 7 · 2013: 2
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Database (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- University of Cambridge
- Biotechnology and Biological Sciences Research Council (1103577)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- protein-protein interaction, small molecules, therapeutic target, protein complexes, chemical modulators, protein stabilization, database updates
- MeSH terms
- Databases as Topic, Databases, Protein, Small Molecule Libraries, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
